IR@PKUHSC  > 北京大学第一临床医学院  > 感染疾病科
学科主题临床医学
Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B A Prospective Observational Study
Jia, Wei1,2; Song, Liu-Wei3; Fang, Yu-Qing1,2; Wu, Xiao-Feng4; Liu, Dan-Yang4; Xu, Chun4; Wang, Xiao-Mei4; Wang, Wen4; Lv, Dong-Xia4; Li, Jun1,2; Deng, Yong-Qiong1,2; Wang, Yan1,2; Huo, Na1,2; Yu, Min1,2; Xi, Hong-Li1,2; Liu, Dan1,2; Zhou, Yi-Xing1,2; Wang, Gui-Qiang1,2; Xia, Ning-Shao3; Zhang, Ming-Xiang4
刊名MEDICINE
2014-12-01
DOI10.1097/MD.0000000000000322
93期:29
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]VIRUS INFECTION ; POSITIVE PATIENTS ; SEROCONVERSION ; PERSPECTIVE ; HBSAG ; HELP ; HBC
英文摘要

Previous studies have revealed antibody to hepatitis B core antigen (anti-HBc) levels as a predictor of treatment response in hepatitis B early antigen (HBeAg)-positive chronic hepatitis B (CHB) patients in both interferon and nucleos(t) ide analog therapy cohorts. However, there is no information about anti-HBc levels in the natural history of CHB.

This study aimed to define anti-HBc levels of different phases in the natural history of CHB.

Two hundred eleven treatment-naive CHB patients were included in the study. They were classified into 4 phases: immune tolerance (IT) phase (n = 39), immune clearance (IC) phase (n = 48), low or no-replicative (LR) phase (n = 55), andHBeAg-negative hepatitis(ENH, n = 69). Fifty patients who were HBsAg negative and anti-HBc positive were also recruited as past HBV infection (PBI) control group. Anti-HBc levels were measured by a newly developed double-sandwich immunoassay. Correlation of anti-HBc levels with alanine aminotransferase (ALT) and other HBV-related markers within each phase was performed.

Serum anti-HBc levels were statistically significant between patients in different phases of CHB (P < 0.001). The median anti-HBc levels were: IT (3.17 log(10) IU/mL), IC (4.39 log(10) IU/mL), LR (3.29 log(10) IU/mL), ENH (4.12 log(10) IU/mL), and PBI (0.61 log(10) IU/mL). There existed a strong correlation in IC (r = 0.489, P< 0.001), a poor correlation in ENH (r = 0.275, P = 0.042), and no correlation in patients with ALT reached 5 times upper limit of normal (r = 0.120, P = 0.616).

Anti-HBc levels show significant differences during the natural course of CHB. These results may provide some potentially useful insights into hepatitis B pathogenesis and immune activation against hepatitis B virus.

语种英语
WOS记录号WOS:000346985700025
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59609
专题北京大学第一临床医学院_感染疾病科
作者单位1.Peking Univ, Hosp 1, Ctr Liver Dis, Beijing 100034, Peoples R China
2.Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100034, Peoples R China
3.Xiamen UniversityFujian, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Peoples R China
4.Sixth Hosp ShenyangLiaoning, Dept Infect Dis, Shenyang, Peoples R China
推荐引用方式
GB/T 7714
Jia, Wei,Song, Liu-Wei,Fang, Yu-Qing,et al. Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B A Prospective Observational Study[J]. MEDICINE,2014,93(29).
APA Jia, Wei.,Song, Liu-Wei.,Fang, Yu-Qing.,Wu, Xiao-Feng.,Liu, Dan-Yang.,...&Zhang, Ming-Xiang.(2014).Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B A Prospective Observational Study.MEDICINE,93(29).
MLA Jia, Wei,et al."Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B A Prospective Observational Study".MEDICINE 93.29(2014).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Jia, Wei]的文章
[Song, Liu-Wei]的文章
[Fang, Yu-Qing]的文章
百度学术
百度学术中相似的文章
[Jia, Wei]的文章
[Song, Liu-Wei]的文章
[Fang, Yu-Qing]的文章
必应学术
必应学术中相似的文章
[Jia, Wei]的文章
[Song, Liu-Wei]的文章
[Fang, Yu-Qing]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。